Isto Biologics Launches Influx Fibrant Allograft

Isto Biologics introduced Influx™ Fibrant, a line of functional constructs derived from 100% cortical allograft.

The Fibrant launch features the patented technology platform that Isto Biologics' recent acquisition of TheraCell brings to Isto's expanding portfolio of orthopedic allografts.

Isto's Fibrant Technology processes produce uniform...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0